Valuation: Bayer AG

Market Cap 47.61B 54.32B 44.01B 40.47B 76.37B 5,238B 77.59B 526B 206B 2,563B 204B 200B 8,830B P/E 2026 *
20.9x
P/E 2027 * 15.7x
Enterprise Value 79.45B 90.64B 73.44B 67.54B 127B 8,741B 129B 878B 344B 4,277B 340B 333B 14,735B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.63x
Free-Float
100%
Yield 2026 *
0.47%
Yield 2027 * 1.3%
1 week-5.74%
Current month+0.88%
1 month+29.90%
3 months+16.61%
6 months+17.35%
Current year+33.38%
1 week 205.3
Extreme 205.3
216
1 month 159.05
Extreme 159.05
230.5
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.74%+75.41%-10.02% 54.48B
-1.37%-1.25%+53.13%+151.63% 1,051B
-1.26%-2.72%+52.56%+48.92% 609B
-0.46%+2.30%+37.25%+78.42% 450B
-0.75%+0.30%+29.77%+21.15% 330B
-1.52%-1.19%+34.46%+35.35% 284B
-1.70%-1.82%+20.99%+15.74% 263B
-0.58%+1.11%-20.18%-40.59% 223B
-0.09%+1.70%+23.90%+57.17% 198B
-0.32%+2.00%+23.78%+67.66% 167B
Average -0.86%+0.54%+33.11%+42.54% 397.23B
Weighted average by Cap. -1.02%+0.02%+38.03%+71.25%

Financials

2026 *2027 *
Net sales 45.6B 52.03B 42.15B 38.77B 73.15B 5,017B 74.32B 504B 198B 2,455B 195B 191B 8,458B 46.76B 53.34B 43.22B 39.75B 75B 5,144B 76.2B 517B 203B 2,517B 200B 196B 8,672B
Net income 2.13B 2.43B 1.97B 1.81B 3.41B 234B 3.47B 23.5B 9.21B 114B 9.11B 8.91B 394B 2.93B 3.35B 2.71B 2.49B 4.7B 323B 4.78B 32.41B 12.71B 158B 12.56B 12.29B 544B
Net Debt 31.84B 36.33B 29.43B 27.07B 51.08B 3,503B 51.89B 352B 138B 1,714B 136B 133B 5,905B 28.71B 32.76B 26.54B 24.41B 46.06B 3,159B 46.79B 317B 124B 1,546B 123B 120B 5,325B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
21/07/26 PLN 205.30 0.00%
17/07/26 PLN 205.30 -0.77%
16/07/26 PLN 206.90 -1.71%
15/07/26 PLN 210.50 -2.55%
14/07/26 PLN 216.00 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.46EUR
Average target price
54.92EUR
Spread / Average Target
+13.32%

Quarterly revenue - Rate of surprise